BioSpace News Archive

Focus on non-small cell lung cancer with a mutation that leads to MET exon 14 skipping, and tumors with amplifications and MET fusions, including glioblastoma multiforme

Flexion Therapeutics, Inc. announced the pricing of an underwritten public offering of 9,230,770 shares of its common stock at a price to the public of $9.75 per share.

Dr. Malte Asseln awarded annual prize by German Society for Biomedical Engineering at the VDE Association and the Klee Family Foundation for his scientific computer-and-image-based workflow to optimize knee implant design

Phenomenex, Inc., a global leader in the research, design and manufacture of advanced technologies for the separation sciences, introduces the bioZen™ 2.6 µm WidePore C4 core-shell LC column to the existing portfolio of bioZen biological workflow products for the reversed phase analysis of intact and subunit monoclonal antibodies

IQVIA™ (NYSE: IQV) today announced the launch of HCP/O Engagement Management, the industry’s first end-to-end, orchestrated healthcare professional/organization (HCP/O) solution that enables the planning, management, contracting, and payment of HCP/Os globally. “IQVIA Technologies is excited to launch its latest offering, HCP/O Engagement Management. As part of IQVIA’s Orchestrated C

In response to the COVID-19 pandemic and in anticipation of the anticipated severe Flu season, LYND, a national apartment management company, today announced that it has selected the BIOPROTECTUs™ System by ViaClean Technologies to disinfect its 20,000 residential units and their associate common areas as well as to provide long term

May 21, 2020 12:07 UTC Expert in biotech, life sciences, cardiovascular dynamics, modeling and simulation to lead bio digital twin initiative; Dr. Hoeteck Wee joins CIS Lab PALO ALTO, Calif.--( BUSINESS WIRE )-- NTT Research, Inc. , a division of NTT (TYO:9432), today announced that it has named Joe Alexander, M.D., Ph.D., as Distinguished Scientist in its Medical and Health Informatics (MEI) Lab . Dr. Alexander, who is also a Fellow of the American College of Cardiolog

Ultragenyx Pharmaceutical, Inc. (Nasdaq: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases and Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT), a leading messenger RNA medicines company, today announced that Ultragenyx has exercised its option to purchase 600,000 shares of Arcturus common stock at $16.00 per share. “We are enco

Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will participate in Craig-Hallum’s 17 th Annual Institutional Investor Conference on Wednesday, May 27, 2020, beginning at 10:00 a.m. ET. Each year, Craig-Hallum hosts a multi-industry investo

The Soileau Family-SPIE Optics and Photonics Undergraduate Scholarship Fund is part of a $2.5 million SPIE education funding initiative for optics and photonics BELLINGHAM, Wash.--( BUSINESS WIRE )-- On 21 May, SPIE, the international society for optics and photonics , announced the establishment of the Soileau Family-SPIE Optics and Photonics Undergraduate Scholarship Fund for the University of Central Florida’s (UCF) College of Optics and Photonics